Fred Kinyuy Tabung, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hyperinsulinism | 16 | 2023 | 415 | 5.440 |
Why?
|
Diet | 61 | 2023 | 7937 | 4.360 |
Why?
|
Inflammation | 43 | 2023 | 10634 | 2.860 |
Why?
|
Feeding Behavior | 23 | 2023 | 3188 | 2.770 |
Why?
|
Postmenopause | 16 | 2023 | 2461 | 1.990 |
Why?
|
Colorectal Neoplasms | 20 | 2023 | 6773 | 1.930 |
Why?
|
Receptors, Tumor Necrosis Factor, Type II | 5 | 2019 | 357 | 1.260 |
Why?
|
C-Peptide | 8 | 2023 | 419 | 1.150 |
Why?
|
Insulin | 11 | 2022 | 6583 | 1.060 |
Why?
|
Diet Surveys | 11 | 2021 | 1173 | 0.950 |
Why?
|
Women's Health | 13 | 2023 | 2034 | 0.920 |
Why?
|
Inflammation Mediators | 4 | 2020 | 1889 | 0.840 |
Why?
|
C-Reactive Protein | 10 | 2020 | 3778 | 0.820 |
Why?
|
Diet, Mediterranean | 6 | 2023 | 700 | 0.820 |
Why?
|
Interleukin-6 | 6 | 2019 | 3201 | 0.760 |
Why?
|
Diabetes Mellitus, Type 2 | 11 | 2023 | 11732 | 0.760 |
Why?
|
Colonic Neoplasms | 3 | 2019 | 2538 | 0.720 |
Why?
|
Risk Factors | 56 | 2023 | 72280 | 0.690 |
Why?
|
Adiponectin | 6 | 2023 | 1100 | 0.680 |
Why?
|
Adenomatous Polyps | 2 | 2021 | 107 | 0.660 |
Why?
|
Life Style | 9 | 2022 | 3835 | 0.650 |
Why?
|
Prospective Studies | 47 | 2023 | 53280 | 0.650 |
Why?
|
Follow-Up Studies | 38 | 2023 | 39045 | 0.610 |
Why?
|
Dairy Products | 1 | 2021 | 498 | 0.600 |
Why?
|
Postprandial Period | 1 | 2019 | 292 | 0.600 |
Why?
|
Nurses | 9 | 2022 | 2461 | 0.560 |
Why?
|
Food | 2 | 2020 | 770 | 0.550 |
Why?
|
Weight Gain | 3 | 2023 | 2292 | 0.540 |
Why?
|
Ovarian Neoplasms | 3 | 2023 | 4837 | 0.530 |
Why?
|
Proportional Hazards Models | 21 | 2022 | 12355 | 0.530 |
Why?
|
Health Personnel | 6 | 2020 | 3216 | 0.510 |
Why?
|
Metabolomics | 2 | 2023 | 1483 | 0.500 |
Why?
|
Middle Aged | 56 | 2023 | 213367 | 0.490 |
Why?
|
Health Behavior | 2 | 2016 | 2636 | 0.470 |
Why?
|
Dyslipidemias | 1 | 2021 | 849 | 0.460 |
Why?
|
Energy Intake | 6 | 2022 | 2148 | 0.450 |
Why?
|
Female | 79 | 2023 | 380197 | 0.450 |
Why?
|
Adenoma | 1 | 2023 | 2174 | 0.430 |
Why?
|
Nutrition Assessment | 4 | 2019 | 723 | 0.420 |
Why?
|
Breast Neoplasms | 9 | 2022 | 20817 | 0.420 |
Why?
|
Aged | 46 | 2023 | 163253 | 0.420 |
Why?
|
Pancreatic Neoplasms | 4 | 2023 | 5257 | 0.410 |
Why?
|
Kidney Neoplasms | 3 | 2023 | 4245 | 0.410 |
Why?
|
Humans | 104 | 2023 | 744220 | 0.380 |
Why?
|
Health Status Indicators | 1 | 2016 | 969 | 0.380 |
Why?
|
Guideline Adherence | 2 | 2021 | 2266 | 0.370 |
Why?
|
Early Detection of Cancer | 3 | 2021 | 3086 | 0.360 |
Why?
|
Cause of Death | 7 | 2023 | 3584 | 0.350 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 3 | 2022 | 2279 | 0.350 |
Why?
|
Exercise | 8 | 2023 | 5615 | 0.330 |
Why?
|
Nutritional Status | 4 | 2023 | 1609 | 0.320 |
Why?
|
Glycemic Index | 2 | 2021 | 395 | 0.320 |
Why?
|
Carcinoma, Renal Cell | 1 | 2023 | 3130 | 0.320 |
Why?
|
Male | 54 | 2023 | 350027 | 0.290 |
Why?
|
Gallstones | 2 | 2020 | 286 | 0.290 |
Why?
|
Liver Neoplasms | 4 | 2023 | 4252 | 0.290 |
Why?
|
United States | 25 | 2023 | 69867 | 0.280 |
Why?
|
Body Mass Index | 11 | 2023 | 12718 | 0.270 |
Why?
|
Chronic Disease | 3 | 2023 | 9147 | 0.270 |
Why?
|
Cardiovascular Diseases | 9 | 2023 | 15161 | 0.270 |
Why?
|
Rectal Neoplasms | 1 | 2014 | 1203 | 0.260 |
Why?
|
Insulin Resistance | 4 | 2022 | 3863 | 0.260 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 2 | 2022 | 1039 | 0.250 |
Why?
|
Diet, Vegetarian | 2 | 2023 | 174 | 0.240 |
Why?
|
Health Promotion | 1 | 2016 | 2205 | 0.240 |
Why?
|
Prostatic Neoplasms | 3 | 2022 | 11074 | 0.230 |
Why?
|
Nutrition Surveys | 4 | 2020 | 1660 | 0.230 |
Why?
|
Incidence | 12 | 2021 | 20945 | 0.230 |
Why?
|
Adult | 34 | 2023 | 214035 | 0.220 |
Why?
|
Obesity | 5 | 2023 | 12742 | 0.220 |
Why?
|
Risk | 4 | 2020 | 9685 | 0.220 |
Why?
|
Risk Assessment | 7 | 2021 | 23337 | 0.220 |
Why?
|
Health | 2 | 2015 | 394 | 0.200 |
Why?
|
Monosaccharides | 1 | 2021 | 70 | 0.190 |
Why?
|
Leisure Activities | 1 | 2022 | 311 | 0.190 |
Why?
|
Nutrition Policy | 2 | 2015 | 488 | 0.180 |
Why?
|
Neoplasms | 5 | 2022 | 21672 | 0.180 |
Why?
|
Chromatography, Liquid | 1 | 2023 | 977 | 0.180 |
Why?
|
Carcinoma, Hepatocellular | 2 | 2023 | 2214 | 0.170 |
Why?
|
Plant Proteins | 1 | 2022 | 364 | 0.170 |
Why?
|
Sex Factors | 3 | 2019 | 10396 | 0.170 |
Why?
|
Fecal Incontinence | 1 | 2022 | 240 | 0.170 |
Why?
|
Practice Guidelines as Topic | 1 | 2016 | 7281 | 0.170 |
Why?
|
Cohort Studies | 13 | 2023 | 40559 | 0.170 |
Why?
|
Dietary Proteins | 2 | 2022 | 963 | 0.170 |
Why?
|
Dietary Carbohydrates | 2 | 2021 | 906 | 0.170 |
Why?
|
Diet, Fat-Restricted | 1 | 2021 | 320 | 0.160 |
Why?
|
Educational Status | 2 | 2016 | 2539 | 0.160 |
Why?
|
Diet Records | 2 | 2017 | 425 | 0.160 |
Why?
|
Severity of Illness Index | 1 | 2016 | 15538 | 0.160 |
Why?
|
Resistance Training | 1 | 2020 | 165 | 0.160 |
Why?
|
Cross-Sectional Studies | 9 | 2022 | 25043 | 0.160 |
Why?
|
Linear Models | 2 | 2021 | 5953 | 0.160 |
Why?
|
Fusobacterium Infections | 1 | 2018 | 53 | 0.160 |
Why?
|
Survival Rate | 3 | 2021 | 12781 | 0.150 |
Why?
|
Financial Management | 1 | 2019 | 160 | 0.150 |
Why?
|
Tandem Mass Spectrometry | 1 | 2023 | 1157 | 0.150 |
Why?
|
Diverticulitis | 1 | 2019 | 171 | 0.150 |
Why?
|
Amino Acids, Branched-Chain | 1 | 2019 | 251 | 0.150 |
Why?
|
Receptors, Tumor Necrosis Factor, Type I | 1 | 2018 | 264 | 0.150 |
Why?
|
Urinary Bladder Neoplasms | 2 | 2020 | 2237 | 0.150 |
Why?
|
Fusobacterium nucleatum | 1 | 2018 | 162 | 0.140 |
Why?
|
South Carolina | 1 | 2016 | 99 | 0.140 |
Why?
|
Ideal Body Weight | 1 | 2016 | 27 | 0.140 |
Why?
|
Health Occupations | 1 | 2018 | 224 | 0.140 |
Why?
|
Multivariate Analysis | 4 | 2018 | 12244 | 0.140 |
Why?
|
Colonic Polyps | 1 | 2021 | 542 | 0.140 |
Why?
|
Periodontitis | 1 | 2021 | 553 | 0.130 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2018 | 4419 | 0.130 |
Why?
|
Leptin | 1 | 2023 | 1599 | 0.130 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2023 | 989 | 0.130 |
Why?
|
DNA, Mitochondrial | 1 | 2020 | 817 | 0.130 |
Why?
|
Prostate | 1 | 2023 | 1773 | 0.130 |
Why?
|
Self Report | 4 | 2020 | 3558 | 0.130 |
Why?
|
Estrogens | 1 | 2022 | 1565 | 0.120 |
Why?
|
Tumor Escape | 1 | 2017 | 349 | 0.120 |
Why?
|
Blood Glucose | 2 | 2021 | 6259 | 0.120 |
Why?
|
Androgens | 1 | 2022 | 1279 | 0.120 |
Why?
|
Coffee | 1 | 2019 | 578 | 0.120 |
Why?
|
Age of Onset | 1 | 2021 | 3270 | 0.120 |
Why?
|
Causality | 1 | 2021 | 1275 | 0.120 |
Why?
|
Precancerous Conditions | 1 | 2021 | 975 | 0.120 |
Why?
|
Neurodegenerative Diseases | 1 | 2023 | 1062 | 0.120 |
Why?
|
Carcinoma, Intraductal, Noninfiltrating | 1 | 2021 | 949 | 0.120 |
Why?
|
Endometrial Neoplasms | 1 | 2023 | 1353 | 0.110 |
Why?
|
Age Factors | 4 | 2021 | 18367 | 0.110 |
Why?
|
History, 21st Century | 1 | 2019 | 1534 | 0.110 |
Why?
|
Gonadal Steroid Hormones | 1 | 2016 | 711 | 0.110 |
Why?
|
Lipid Metabolism | 1 | 2021 | 1888 | 0.110 |
Why?
|
Adolescent Behavior | 1 | 2021 | 1151 | 0.110 |
Why?
|
Frail Elderly | 1 | 2017 | 693 | 0.100 |
Why?
|
Leukocytes | 1 | 2020 | 2040 | 0.100 |
Why?
|
Longitudinal Studies | 3 | 2017 | 13990 | 0.100 |
Why?
|
Dermatitis, Atopic | 1 | 2019 | 654 | 0.100 |
Why?
|
Overweight | 2 | 2023 | 2370 | 0.100 |
Why?
|
DNA Copy Number Variations | 1 | 2020 | 1940 | 0.100 |
Why?
|
Interleukins | 1 | 2016 | 791 | 0.100 |
Why?
|
Psoriasis | 1 | 2019 | 898 | 0.090 |
Why?
|
Regression Analysis | 2 | 2017 | 6461 | 0.090 |
Why?
|
Colitis | 1 | 2018 | 1170 | 0.090 |
Why?
|
Lipids | 1 | 2021 | 3305 | 0.090 |
Why?
|
Sleep Apnea, Obstructive | 1 | 2022 | 1812 | 0.090 |
Why?
|
Kaplan-Meier Estimate | 1 | 2020 | 6535 | 0.090 |
Why?
|
Mortality | 1 | 2021 | 2864 | 0.090 |
Why?
|
Adiposity | 1 | 2019 | 1807 | 0.080 |
Why?
|
Databases, Factual | 2 | 2021 | 7730 | 0.080 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2023 | 3047 | 0.080 |
Why?
|
Case-Control Studies | 3 | 2020 | 21752 | 0.080 |
Why?
|
Logistic Models | 3 | 2022 | 13409 | 0.080 |
Why?
|
Colitis, Ulcerative | 1 | 2020 | 1912 | 0.080 |
Why?
|
Crohn Disease | 1 | 2020 | 2303 | 0.070 |
Why?
|
Health Surveys | 3 | 2021 | 4037 | 0.070 |
Why?
|
Aged, 80 and over | 5 | 2023 | 57768 | 0.070 |
Why?
|
Adenocarcinoma | 1 | 2023 | 6352 | 0.070 |
Why?
|
Coronary Disease | 1 | 2020 | 6078 | 0.070 |
Why?
|
Energy Metabolism | 1 | 2016 | 2895 | 0.060 |
Why?
|
Electronic Health Records | 1 | 2022 | 4463 | 0.060 |
Why?
|
Poverty | 1 | 2016 | 2660 | 0.060 |
Why?
|
Lung | 1 | 2023 | 9852 | 0.060 |
Why?
|
Alcohol Drinking | 1 | 2016 | 3966 | 0.060 |
Why?
|
Receptors, Adiponectin | 1 | 2023 | 81 | 0.060 |
Why?
|
Research Design | 1 | 2019 | 5987 | 0.060 |
Why?
|
Estradiol | 2 | 2022 | 2020 | 0.060 |
Why?
|
Dementia | 1 | 2017 | 2518 | 0.060 |
Why?
|
Aging | 1 | 2022 | 8661 | 0.050 |
Why?
|
Kynurenine | 1 | 2023 | 138 | 0.050 |
Why?
|
Arthritis, Rheumatoid | 1 | 2018 | 3712 | 0.050 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2017 | 2425 | 0.050 |
Why?
|
Socioeconomic Factors | 1 | 2016 | 7784 | 0.050 |
Why?
|
Carbonated Beverages | 1 | 2023 | 214 | 0.050 |
Why?
|
Receptors, Leptin | 1 | 2023 | 360 | 0.050 |
Why?
|
Multiple Myeloma | 1 | 2020 | 5180 | 0.050 |
Why?
|
Odds Ratio | 3 | 2022 | 9849 | 0.050 |
Why?
|
Survival Analysis | 3 | 2020 | 10250 | 0.050 |
Why?
|
Plants | 1 | 2023 | 316 | 0.050 |
Why?
|
Adipokines | 1 | 2023 | 319 | 0.050 |
Why?
|
Tryptophan | 1 | 2023 | 479 | 0.050 |
Why?
|
Weight Loss | 2 | 2023 | 2622 | 0.050 |
Why?
|
Insulin-Like Growth Factor Binding Proteins | 1 | 2022 | 216 | 0.050 |
Why?
|
Sweetening Agents | 1 | 2023 | 296 | 0.050 |
Why?
|
Yogurt | 1 | 2020 | 72 | 0.050 |
Why?
|
Fats | 1 | 2020 | 102 | 0.040 |
Why?
|
Micronutrients | 1 | 2023 | 375 | 0.040 |
Why?
|
Diet, Carbohydrate-Restricted | 1 | 2022 | 262 | 0.040 |
Why?
|
Smoking | 1 | 2016 | 8986 | 0.040 |
Why?
|
Oxidative Stress | 2 | 2020 | 3085 | 0.040 |
Why?
|
Insulin-Like Growth Factor Binding Protein 1 | 1 | 2019 | 123 | 0.040 |
Why?
|
Time Factors | 4 | 2021 | 40063 | 0.040 |
Why?
|
Atherosclerosis | 1 | 2014 | 3444 | 0.040 |
Why?
|
Beverages | 1 | 2023 | 821 | 0.040 |
Why?
|
Canada | 1 | 2023 | 2065 | 0.040 |
Why?
|
Insulin-Like Growth Factor Binding Protein 3 | 1 | 2019 | 423 | 0.040 |
Why?
|
Fibrinogen | 1 | 2020 | 894 | 0.040 |
Why?
|
Sex Hormone-Binding Globulin | 1 | 2019 | 548 | 0.030 |
Why?
|
Leukocytes, Mononuclear | 1 | 2023 | 1836 | 0.030 |
Why?
|
Arthritis, Psoriatic | 1 | 2019 | 215 | 0.030 |
Why?
|
Brazil | 1 | 2020 | 1270 | 0.030 |
Why?
|
Plasma | 1 | 2019 | 575 | 0.030 |
Why?
|
Molecular Epidemiology | 1 | 2017 | 468 | 0.030 |
Why?
|
Confidence Intervals | 1 | 2021 | 2970 | 0.030 |
Why?
|
Analgesics | 1 | 2022 | 1040 | 0.030 |
Why?
|
Liver Diseases | 1 | 2023 | 1254 | 0.030 |
Why?
|
Vegetables | 1 | 2020 | 1182 | 0.030 |
Why?
|
Comorbidity | 2 | 2019 | 10387 | 0.030 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2022 | 2014 | 0.030 |
Why?
|
Adolescent | 4 | 2022 | 85759 | 0.030 |
Why?
|
Metabolome | 1 | 2020 | 895 | 0.030 |
Why?
|
Liver Cirrhosis | 1 | 2023 | 1864 | 0.030 |
Why?
|
Cholesterol, HDL | 1 | 2019 | 1814 | 0.030 |
Why?
|
Body Weight | 1 | 2022 | 4666 | 0.020 |
Why?
|
Triglycerides | 1 | 2019 | 2453 | 0.020 |
Why?
|
Epidemiologic Studies | 1 | 2014 | 676 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2022 | 3584 | 0.020 |
Why?
|
Infant | 2 | 2023 | 35129 | 0.020 |
Why?
|
Aspirin | 1 | 2022 | 3282 | 0.020 |
Why?
|
Neoplasm Invasiveness | 1 | 2018 | 3614 | 0.020 |
Why?
|
Prognosis | 2 | 2022 | 29050 | 0.020 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2018 | 1509 | 0.020 |
Why?
|
Vitamin D | 1 | 2023 | 3222 | 0.020 |
Why?
|
Mammography | 1 | 2020 | 2477 | 0.020 |
Why?
|
Intestinal Mucosa | 1 | 2020 | 3036 | 0.020 |
Why?
|
Testosterone | 1 | 2019 | 2411 | 0.020 |
Why?
|
Mental Recall | 1 | 2013 | 1205 | 0.020 |
Why?
|
Mitochondria | 1 | 2020 | 3520 | 0.020 |
Why?
|
Genomics | 1 | 2022 | 5722 | 0.020 |
Why?
|
Phenotype | 1 | 2023 | 16365 | 0.020 |
Why?
|
Biopsy | 1 | 2017 | 6757 | 0.020 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2023 | 15525 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2020 | 12264 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2018 | 9960 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2021 | 25618 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2017 | 8426 | 0.010 |
Why?
|
Quality of Life | 1 | 2022 | 12805 | 0.010 |
Why?
|
Massachusetts | 1 | 2013 | 8663 | 0.010 |
Why?
|
Pregnancy | 1 | 2022 | 29142 | 0.010 |
Why?
|
Animals | 2 | 2022 | 168788 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2020 | 17449 | 0.010 |
Why?
|
Child, Preschool | 1 | 2021 | 40992 | 0.010 |
Why?
|
Young Adult | 1 | 2021 | 56436 | 0.010 |
Why?
|
Child | 1 | 2021 | 77679 | 0.010 |
Why?
|
Mutation | 1 | 2017 | 29784 | 0.010 |
Why?
|